{"version":"https://jsonfeed.org/version/1","title":"Disrupt Connect","home_page_url":"https://disruptconnect.com","description":"Disrupt Connect","author":{"name":"Disrupt Connect"},"items":[{"id":"from-lab-to-launch-building-your-commercialization-playbook","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/5ce11b81-e8de-49ff-a012-0ed991218d1b/Tactical%20Strategic-e2c12c3.png\"/><p>Most biotech companies have launch checklists. What they need is a commercialization playbook—and there's a critical difference.</p>","url":"https://disruptconnect.com/our-insights/f/from-lab-to-launch-building-your-commercialization-playbook","title":"From Lab to Launch: Building Your Commercialization Playbook","date_modified":"2025-12-17T17:21:20Z"},{"id":"from-lab-to-launch-the-critical-gap-most-biotech-companies-miss","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/5ce11b81-e8de-49ff-a012-0ed991218d1b/Gemini_Generated_Image_4x9w7d4x9w7d4x9w%20(1).png\"/><p>The innovation pipeline is full. The commercial pipeline is empty.</p>","url":"https://disruptconnect.com/our-insights/f/from-lab-to-launch-the-critical-gap-most-biotech-companies-miss","title":"From Lab to Launch: The Critical Gap Most Biotech Companies Miss","date_modified":"2025-11-10T20:49:28Z"}]}